Chen Jing 4
4 · Biostage, Inc. · Filed Nov 10, 2021
Insider Transaction Report
Form 4
Biostage, Inc.BSTG
Chen Jing
Director
Transactions
- Award
Stock Option (right to buy)
2021-07-01+22,500→ 22,500 totalExercise: $1.35Exp: 2031-07-01→ Common Stock, par value $0.01 per share (22,500 underlying) - Award
Stock Option (right to buy)
2021-07-01+18,035→ 40,535 totalExercise: $1.35Exp: 2031-07-01→ Common Stock, par value $0.01 per share (18,035 underlying)
Footnotes (2)
- [F1]This Stock Option represents the annual equity grant to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on October 1, 2021, January 1, 2022, April 1, 2022 and July 1, 2022.
- [F2]This Stock Option was granted in lieu of cash compensation otherwise payable to the Reporting Person, as a non-employee director of the Issuer, and will vest in four equal installments on the grant date, October 1, 2021, January 1, 2022 and April 1, 2022.